Pfizer posts surprise 4th quarter profit, but key products miss on sales
Pfizer reported a surprise quarterly profit on Tuesday, helped by cost cuts and fewer returns of its COVID treatment Paxlovid by the U.S. government than it had expected, but sales of some high profile products fell short of Wall Street estimates. The New York-based drugmaker earned 10 cents per…
#pfizer #jeffjonas #gabellifunds #ibrance #prevnar #albertbourla #rsv #abrysvo #gskibrance #comirnaty